EB1 acts as an oncogene via activating β-catenin/TCF pathway to promote cellular growth and inhibit apoptosis

Molecular Carcinogenesis

Volumn 48, Issue 3, 2009, Pages 212-219

  Liu, Mei ^a   Yang, Shangbin ^a,b   Wang, Yihua ^a,c   Zhu, Hongxia ^a   Yan, Shuang ^a   Zhang, Wei ^a   Quan, Lanping ^a   Bai, Jinfeng ^a   Xu, Ningzhi ^a  

^a CANCER HOSPITAL   (China)

^b OHIO STATE UNIVERSITY   (United States)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

catenin; EB1; Induced; Overexpression

Indexed keywords

BETA CATENIN; CISPLATIN; DOXYCYCLINE; END BINDING PROTEIN 1; PROTEIN; PROTEIN BCL 2; T CELL FACTOR PROTEIN; T CELL FACTOR PROTEIN 4; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CTNNB1 PROTEIN, HUMAN; MAPRE1 PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; MYC PROTEIN; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL GROWTH; COLONY FORMATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION INITIATION; UPREGULATION; ANIMAL; CELL CULTURE; CELL NUCLEUS; CLONOGENIC ASSAY; DRUG EFFECT; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; KIDNEY; METABOLISM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

MUS MUSCULUS;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BETA CATENIN; BLOTTING, WESTERN; CELL NUCLEUS; CELLS, CULTURED; CISPLATIN; COLONY-FORMING UNITS ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY; MICE; MICE, NUDE; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASMS, EXPERIMENTAL; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TCF TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 62349115588     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20471     Document Type: Article

References (25)

1. Su LK, Burrell M, Hill DE, et al. APC binds to the novel protein EB1. Cancer Res 1995;55:2972-2977.
2. Berrueta L, Kraeft SK, Tirnauer JS, et al. The adenomatous polyposis coli-binding protein EB1 is associated with cytoplasmic and spindle microtubules. Proc Natl Acad Sci USA 1998;95:10596-10601.
3. Tirnauer JS, Bierer BE. EB1 proteins regulate microtubule dynamics, cell polarity, and chromosome stability. J Cell Biol 2000;149:761-766.
4. Zhou J, Liu Z, Wang X, et al. Gene expression profiles in squamous esophageal cancer tissues and adjacent almost normal tissues. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 1999; 16:303-306.
5. Nishigaki R, Osaki M, Hiratsuka M, et al. Proteomic identification of differentially-expressed genes in human gastric carcinomas. Proteomics 2005;5:3205-3213.
6. Fujii K, Kondo T, Yokoo H, Yamada T, Iwatsuki K, Hirohashi S. Proteomic study of human hepatocellular carcinoma using two-dimensional difference gel electrophoresis with saturation cysteine dye. Proteomics 2005;5:1411-1422.
7. El-Rifai W, Frierson HF, Jr., Harper JC, Powell SM, Knuutila S. Expression profiling of gastric adenocarcinoma using cDNA array. Int J Cancer 2001;92:832-838.
8. Wang Y, Zhou X, Zhu H, et al. Overexpression of EB1 in human esophageal squamous cell carcinoma (ESCC) may promote cellular growth by activating beta-catenin/TCF pathway. Oncogene 2005;24:6637-6645.
9. Hsieh PC, Chang JC, Sun WT, Hsieh SC, Wang MC, Wang FF. p53 downstream target DDA3 is a novel microtubule-associated protein that interacts with end-binding protein EB3 and activates beta-catenin pathway. Oncogene 2007; 19:19.
10. Shtutman M, Zhurinsky J, Simcha I, et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 1999;96:5522-5527.
11. Polakis P. Wnt signaling and cancer. Genes Dev 2000;14: 1837-1851.
12. He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway. Science 1998;281:1509-1512.
13. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999;398:422-426.
14. Li H, Pamukcu R, Thompson WJ. beta-Catenin signaling: Therapeutic strategies in oncology. Cancer Biol Ther 2002;1:621-625.
15. Wang YH, Liu S, Zhang G, et al. Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo. Breast Cancer Res 2005;7:R220-R228.
16. Zhou C, Liu S, Zhou X, et al. Overexpression of human pituitary tumor transforming gene (hPTTG), is regulated by beta-catenin/TCF pathway in human esophageal squamous cell carcinoma. Int J Cancer 2005;113:891-898.
17. Hueber PA, Waters P, Clark P, Eccles M, Goodyer P. PAX2 inactivation enhances cisplatin-induced apoptosis in renal carcinoma cells. Kidney Int 2006;69:1139-1145.
18. Ishitani T, Ninomiya-Tsuji J, Nagai S, et al. The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF. Nature 1999;399:798-802.
19. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-619.
20. Chen S, Guttridge DC, You Z, et al. Wnt-1 signaling inhibits apoptosis by activating beta-catenin/T cell factor-mediated transcription. J Cell Biol 2001;152:87-96.
21. Yang X, Zheng F, Xing H, et al. Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer. J Cancer Res Clin Oncol 2004;130:423-428.
22. Raspollini MR, Castiglione F, Degl'Innocenti DR, et al. Bcl-2 in ovarian carcinoma: A clinicopathologic, immunohistochemical and molecular study. Pathologica 2004;96:465-469.
23. Li D, Ueta E, Kimura T, Yamamoto T, Osaki T. Reactive oxygen species (ROS) control the expression of Bcl-2 family proteins by regulating their phosphorylation and ubiquitination. Cancer Sci 2004;95:644-650.
24. Kausch I, Jiang H, Thode B, Doehn C, Kruger S, Jocham D. Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma. Eur Urol 2005;47:703-709.
25. Li Q, Dashwood WM, Zhong X, Nakagama H, Dashwood RH. Bcl-2 overexpression in PhIP-induced colon tumors: Cloning of the rat Bcl-2 promoter and characterization of a pathway involving beta-catenin, c-Myc and E2F1. Oncogene 2007; 2:2.